No definitive evidence currently proves a direct causal link between CJC-1295, ipamorelin, and cancer
IGF-1 Upregulation Downstream Anabolic Signaling Both peptides indirectly stimulate insulin-like growth factor-1 (IGF-1) production through sustained growth hormone elevation: Growth hormone binds to hepatic GH receptors activating JAK-STAT signaling pathways Increased transcription of IGF-1 gene in liver tissue Elevated plasma IGF-1 levels mediate anabolic effects in muscle, bone, and adipose tissue IGF-1 provides negative feedback regulation preventing excessive growth hormone secretion Studies report IGF-1 increases of 1.5- to 3-fold for 9-11 days following CJC-1295 administration, with the ipamorelin combination providing more sustained elevation
Telomerase helps maintain their length, thus maintaining the youthfulness of our cells
SKU: TES/IPA-5MG The Tesamorelin / Ipamorelin Blend combines two extensively studied research peptides into a single formulation designed for laboratory investigations involving growth hormone-related signaling pathways and endocrine communication networks
Each peptide has unique stability requirements, so temperature-controlled shipping and adherence to optimal storage conditions are vital to maintaining the integrity of formulations throughout the study
